Serum alpha-fetoprotein (AFP) is the current standard of care and only approved biomarker for hepatocellular carcinoma (HCC), used for diagnosis, outcome prediction, long-term follow-up, and treatment ...
Serum AFP levels, to some extent, may correlate with prognosis. A large multicenter study of over 1000 patients with HCC recorded that 18% had a serum AFP level of greater than 400 ng/ml and that ...
Conventional-dose chemotherapy as first salvage in germ cell tumors: Outcomes from an Ibero-American multi-institutional cohort. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary ...
First report on the characterization of public and private patients with ovarian cancer in Chile. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results